Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥60.23 - CN¥89.89
Next Earnings Date
Apr 25 2025
Next Earnings Date
Apr 25 2025
Latest price
Market Cap | CN¥82.07B |
EV | CN¥77.26B |
Shares Outstanding | 1.27B |
Beta | 2.25 |
Analyst Rating | HOLD |
Analyst Target Price | CN¥60.15 |
P/E 2025E | 36.40x |
P/Revenue 2025E | 32.79x |
Revenue | -26.90% |
EPS | -63.40% |
Operating Cash Flow | -40.50% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 78.20% |
Net Profit Margin 2025E | 4.90% |
ROE 2025E | 1.00% |
ROCE 2024 | 0.85% |
DPS 2025E | CN¥0.02 |
Payout Ratio 2025E | 20.00% |
Div. Yield 2025E | 0.03% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Sector
Healthcare
Industry
Biotechnology
CEO
Jiang, Zhiming
Employees
3,790
Website
www.ystwt.comIPO Date
2020-04-29
Headquarters
No. 31 Science Park Road, Changping District, Beijing 102206, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved